Skip to main content

Global Hemostasis Tests Market Predicts Robust Growth Until 2033: Prothrombin and Activated Prothrombin Tests in the Spotlight -

The "Hemostasis Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033" report has been added to's offering.

The global hemostasis tests market is experiencing notable trends and developments in the field of in vitro diagnostics. This market is projected to exhibit significant growth from 2023 to 2033. The impact of COVID-19 on the hemostasis tests market in 2020 and beyond has been carefully assessed.

Prothrombin (PT) and Activated Prothrombin (aPTT) tests are among the most widely used hemostasis tests. These tests find frequent application in coagulation testing before surgical procedures. Preoperative coagulation testing is performed in a substantial percentage of cases, typically ranging from 39% to 55%. It is often conducted even when there is no indication from the patient's bleeding history. PT tests are also used to monitor patients taking vitamin K antagonists like warfarin, phenprocoumon, and acenocoumarol.

The Hemostasis Tests market encompasses a range of tests, including:

  • Prothrombin Time Point of Care (POC) Tests
  • Prothrombin Time Laboratory Tests
  • Activated Partial Thromboplastin Time Point of Care (POC) Tests
  • Activated Partial Thromboplastin Time Laboratory Tests
  • D-Dimer Point of Care (POC) Tests
  • D-Dimer Laboratory Tests

The market model offers comprehensive insights, including epidemiology-based indications with procedure volumes. It provides transparency through interactive Excel deliverables, covering aspects such as installed base, new sales volumes, product usage, average selling prices, market size, and company share/rank analysis (wherever available). Moreover, analyst comments provide qualitative context for quantitative data.

Key Inclusions of the Market Model:

  • Review of key industry trends.
  • Annualized total Hemostasis Tests market revenue by segment and market outlook from 2015-2033.
  • Market-level data on units, average selling prices, and market values.

Global, Regional, and Country-level Insights:

  • Qualitative market-specific information with global trends further broken down into regional trends.
  • Country-specific insights on the market.
  • SWOT analysis for the Hemostasis Tests market.
  • Competitive dynamics insights and trends in the market.

The model offers a deep understanding of the market, including an overview of the healthcare system and insights into reimbursement policies and the regulatory landscape.

Country-Specific Information:

  • Overview of the healthcare system.
  • Reimbursement policies specific to each country.
  • Medtech regulatory landscape in each country.

Robust methodologies and sources ensure the model provides an extensive and accurate market overview. Demand and supply-side primary sources are integrated, including Key Opinion Leaders. Real-world data sources, such as government procedure databases, hospital purchasing databases, and proprietary online databases, are leveraged to identify market trends.

Key Companies Mentioned:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens AG
  • Diagnostica Stago SAS
  • Werfen Life Group SAU
  • Bio-Rad Laboratories Inc
  • bioMerieux SA
  • Quidelortho Corp
  • Danaher Corp
  • PerkinElmer Inc

Countries Covered:

  • United States
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Brazil
  • China
  • India
  • Russia
  • Japan
  • Australia
  • Canada
  • Mexico
  • South Korea
  • Denmark
  • Ireland
  • Netherlands
  • New Zealand
  • South Africa
  • Sweden
  • Switzerland
  • Austria
  • Belgium
  • Finland
  • Israel
  • Norway
  • Poland
  • Portugal
  • Taiwan
  • Czech Republic
  • Greece
  • Hungary
  • Turkey
  • Egypt
  • Saudi Arabia
  • United Arab Emirates
  • Argentina
  • Chile

Reasons to Buy:

The model provides valuable insights for stakeholders in the Hemostasis Tests market, allowing them to:

  • Understand the impact of COVID-19 on the market.
  • Develop in-licensing and out-licensing strategies.
  • Formulate business strategies based on market trends.
  • Identify emerging players with strong product portfolios.
  • Track device sales in the global and country-specific Hemostasis Tests market.
  • Organize sales and marketing efforts by identifying market categories and segments with maximum opportunities for consolidations, investments, and partnerships.

For more information about this report visit

Source: GlobalData

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.